FILE:JNJ/JNJ-8K-20070614163212.txt.gz
EVENTS:	Financial Statements and Exhibits
TEXT:
ITEM: Financial Statements and Exhibits
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 12, 2007 JOHNSON & JOHNSON (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or Other Jurisdic- (Commission (IRS Employer tion of Incorporation) File Number) Identification No.) One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: 732-524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 12, 2007, William D. Perez, President and Chief Executive Officer of the Wm. Wrigley Jr. Company, was appointed to the Board of Directors of Johnson & Johnson. Mr. Perez was named to the Compensation & Benefits Committee and the Public Policy Advisory Committee of the Board. The Company's press release announcing the appointment is attached to this Report as Exhibit 99.1. Item 9.01. Financial Statements and Exhibits. (c) Exhibits. 99.1 Press release dated June 12, 2007. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JOHNSON & JOHNSON (Registrant) Date: June 12, 2007 By: /s/ S. M. Rosenberg S. M. Rosenberg Secretary EXHIBIT INDEX Exhibit No. Description 99.1 Press release dated June 12, 2007.

Exhibit 99.1 Press Contact: Jeffrey J. Leebaw 732-524-3350 FOR IMMEDIATE RELEASE William D. Perez of Wm. Wrigley Jr. Company Appointed to Johnson & Johnson Board of Directors New Brunswick, NJ (June 12, 2007) - Johnson & Johnson (JNJ: NYSE) today announced that its Board of Directors has unanimously appointed William D. Perez, President and Chief Executive Officer of the Wm. Wrigley Jr. Company, as a Director of Johnson & Johnson, the world's most broadly based health care products company. Mr. Perez became President and Chief Executive Officer of the Wm. Wrigley Jr. Company, a leading global confectioner and the world's largest manufacturer and marketer of chewing gum, in October, 2006. Before joining Wrigley, he served as President and Chief Executive Officer of Nike, Inc. Previously, Mr. Perez spent 34 years with SC Johnson, including eight years as President and Chief Executive Officer of the privately-held global consumer products company. "Bill's vast and diverse experience in leading global consumer businesses will be invaluable, particularly to the continuing growth of our premier consumer health care business," said William C. Weldon, Chairman and Chief Executive Officer of Johnson & Johnson. "We look forward to Bill's keen insights and business perspectives, and we welcome him to the Board." Mr. Perez received his bachelor of arts degree in government from Cornell University and a graduate degree from the American Graduate School of International Management. He serves on the Board of Directors for Hallmark Cards, Inc., the Grocery Manufacturers Association and Cornell University Council. Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 250 Johnson & Johnson operating companies employ approximately 121,000 men and women in 57 countries and sell products throughout the world. ###


